49 research outputs found
Epidemiology in Latin America and the Caribbean: current situation and challenges
Background This article analyses the epidemiological research developments in Latin America and the Caribbean (LAC). It integrates the series commissioned by the International Epidemiological Association to all WHO Regions to identify global opportunities to promote the development of epidemiology
Consumption of single cigarettes and quitting behavior: A longitudinal analysis of Mexican smokers
<p>Abstract</p> <p>Background</p> <p>Previous cross-sectional research has suggested single cigarettes could either promote or inhibit consumption. The present study aimed to assess the effects of single cigarette availability and consumption on downstream quit behavior.</p> <p>Methods</p> <p>We analyzed population-based, longitudinal data from adult smokers who participated in the 2008 and 2010 administrations of the International Tobacco Control Policy Evaluation Survey in Mexico.</p> <p>Results</p> <p>At baseline, 30% of smokers saw single cigarettes for sale on a daily basis, 17% bought singles at their last purchase, and 7% bought singles daily. Smokers who most frequently purchased singles, both in general and specifically to control their consumption, were no more likely to attempt to quit over the 14 month follow-up period than those who did not purchase singles. Frequency of buying singles to reduce consumption had a non-monotonic association with being quit at followup. The odds of being quit was only statistically significant when comparing those who had not bought singles to reduce consumption with those who had done so on a more irregular basis (AOR = 2.30; 95% CI 1.19, 4.45), whereas those who did so more regularly were no more likely to be quit at followup. Frequency of self-reported urges to smoke upon seeing singles for sale was unassociated with either quit attempts or being quit at followup.</p> <p>Conclusions</p> <p>These results suggest that the relationship between singles consumption and quit behavior is complex, with no clear evidence that singles either promote or inhibit downstream quit behavior.</p
Methodologies used to estimate tobacco-attributable mortality: a review
<p>Abstract</p> <p>Background</p> <p>One of the most important measures for ascertaining the impact of tobacco on a population is the estimation of the mortality attributable to its use. To measure this, a number of indirect methods of quantification are available, yet there is no consensus as to which furnishes the best information. This study sought to provide a critical overview of the different methods of attribution of mortality due to tobacco consumption.</p> <p>Method</p> <p>A search was made in the Medline database until March 2005 in order to obtain papers that addressed the methodology employed for attributing mortality to tobacco use.</p> <p>Results</p> <p>Of the total of 7 methods obtained, the most widely used were the prevalence methods, followed by the approach proposed by Peto et al, with the remainder being used in a minority of studies.</p> <p>Conclusion</p> <p>Different methodologies are used to estimate tobacco attributable mortality, but their methodological foundations are quite similar in all. Mainly, they are based on the calculation of proportional attributable fractions. All methods show limitations of one type or another, sometimes common to all methods and sometimes specific.</p
Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease.
This is the final version. Available from Nature Research via the DOI in this record. Data availability:
The UK Biobank phenotype and WES data described here are publicly available to registered researchers through the UK Biobank data access protocol. Information about registration for access to the data is available at https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access. Data for this study were obtained under resource applications 26041 and 9905. The MCPS welcomes open-access and collaboration data requests from bona fide researchers. For more details on accessibility, the study’s data and sample sharing policy can be downloaded (in English or Spanish) from https://www.ctsu.ox.ac.uk/research/mcps. Available study data can be examined in detail through the study’s Data Showcase, available at https://datashare.ndph.ox.ac.uk/mexico/. SCOOP and INTERVAL WES data are accessible from the European Genome-phenome Archive with accession numbers EGAS00001000124 (SCOOP) and EGAS00001000825 (INTERVAL). snRNA-seq data are available from the NCBI Gene Expression Omnibus (GEO), under accession number: GSE243112. Source data are provided with this paper.Code availability:
The pipeline code for processing, filtering, annotating and burden testing UK Biobank WES data using the UK Biobank RAP is publicly available (https://github.com/mrcepid-rap). No custom code for analyzing the UK Biobank WES data was developed for this study. The analysis code for single-nucleus sequencing is available on GitHub (https://github.com/mariachukanova1/BSN_paper) and has been deposited on Zenodo at https://doi.org/10.5281/zenodo.10687754.Obesity is a major risk factor for many common diseases and has a substantial heritable component. To identify new genetic determinants, we performed exome-sequence analyses for adult body mass index (BMI) in up to 587,027 individuals. We identified rare loss-of-function variants in two genes (BSN and APBA1) with effects substantially larger than those of well-established obesity genes such as MC4R. In contrast to most other obesity-related genes, rare variants in BSN and APBA1 were not associated with normal variation in childhood adiposity. Furthermore, BSN protein-truncating variants (PTVs) magnified the influence of common genetic variants associated with BMI, with a common variant polygenic score exhibiting an effect twice as large in BSN PTV carriers than in noncarriers. Finally, we explored the plasma proteomic signatures of BSN PTV carriers as well as the functional consequences of BSN deletion in human induced pluripotent stem cell-derived hypothalamic neurons. Collectively, our findings implicate degenerative processes in synaptic function in the etiology of adult-onset obesity.Medical Research CouncilMedical Research CouncilMedical Research CouncilMedical Research CouncilWellcome TrustMedical Research CouncilWellcome TrustWellcome Trust and Royal SocietyChan Zuckerberg InitiativeBiotechnology and Biological Sciences Research Council (BBSRC)Mexican Health MinistryNational Council of Science and Technology for MexicoCancer Research UKBritish Heart FoundationNational Institute for Health ResearchCambridge Biomedical Research CentreBotnar FoundationBernard Wolfe Health Neuroscience EndowmentResearch Englan
Renal and vascular diseases are under-counted as underlying causes of death in diabetic populations: Prospective study of 150,000 Mexicans followed for 10 years
Conventional coding rules for death certificates substantially over-count diabetes mellitus as the underlying cause, and correspondingly under-count other conditions such as vascular or renal disease. For, among patients with diabetes reported on the death certificate, conventional rules ascribe vascular or renal deaths to the accompanying diabetes. Thus, although “underlying cause” is defined appropriately by the World Health Organization (WHO) as “the disease or injury which initiated the train of morbid events leading directly to death”, conventional WHO coding rules do not necessarily provide it. We explore the relevance of this to renal and vascular mortality in Mexico, where diabetes is common, and assess separately the substantial overall importance of diabetes
Renal and vascular diseases are under-counted as underlying causes of death in diabetic populations: Prospective study of 150,000 Mexicans followed for 10 years
Conventional coding rules for death certificates substantially over-count diabetes mellitus as the underlying cause, and correspondingly under-count other conditions such as vascular or renal disease. For, among patients with diabetes reported on the death certificate, conventional rules ascribe vascular or renal deaths to the accompanying diabetes. Thus, although “underlying cause” is defined appropriately by the World Health Organization (WHO) as “the disease or injury which initiated the train of morbid events leading directly to death”, conventional WHO coding rules do not necessarily provide it. We explore the relevance of this to renal and vascular mortality in Mexico, where diabetes is common, and assess separately the substantial overall importance of diabetes